Skip to content

To study the effectiveness of psychological therapy in patients with schizophrenia

A randomized control trial to study the efficacy of Tamil version of Metacognitive Training in patients with schizophrenia in Coimbatore - MCT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017658
Enrollment
70
Registered
2019-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F20- Schizophrenia

Interventions

Intervention1: Metacognitive Training: Schizophrenia is a neuropsychiatric disorder which predominantly affects thought processes and neurocognition. Researches have shown that patients with schizophr

Sponsors

Dr B Ravishankar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.primary diagnosis of schizophrenia confirmed by Mini International Neuropsychiatric Interview (M.I.N.I), supplemented by DSM-V and clinical diagnosis. 2.participants should have at least 8 years of education 3.participants should have provided informed consent 4.participants should be able to read and speak Tamil language 5.all participant should be symptomatically stable at the time of enrollment, 6.Positive and Negative Syndrome Scale (PANSS) scores should be under 75, ratings of 3 (mild) or less on the PANSS psychosis items.

Exclusion criteria

Exclusion criteria: 1.any co-morbid psychiatric disorder, neurological disorders 2.history of substance or alcohol, formal thought disorder, aggressive behavior 3.IQ <70

Design outcomes

Primary

MeasureTime frame
Outcome Name: â?¢ Score on Positive and Negative Symptom Scale (PANSS) Expected Outcome: â?¢ The experimentalintervention group is expected to show 40% reduction in the PANSS score whereas the control or the treatment as usual group is expected to show 10% reduction in the PANSS score. Timepoint: After 2 weeks, 6 months and 1 year of completion of intervention

Secondary

MeasureTime frame
â?¢To study the effect of metacognitive therapy on patientâ??s insight â?¢To study the relationship of positive symptom(as assessed by PANSS)and insight â?¢To study the effect of metacognitive therapy on the patientâ??s beliefs â?¢To study if the metacognitive therapy improves patientâ??s metacognitive functioning â?¢To study if effect of metacognitive therapy on patientâ??s functioningTimepoint: 2 weeks, 6 months and one year after the intervention termination.

Countries

India

Contacts

Public ContactDr B Ravishankar

Krishna Nursing Home

drravishankarbalu@gmail.com9443336742

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026